CYFRA21-1 as a Serum Tumor Marker for Follow-Up Patients with Squamous Cell Lung Carcinoma and Oropharynx Squamous Cell Carcinoma

Abstract

The CYFRA21-1 assay demonstrated a greater sensitivity for recurrent stages of SCLC and OSCC, and may prove beneficial in the prediction of SCLC and OSCC recurrence at an earlier date.